美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Drugs Made in America Acquisition Corp. II

10.10

+0.00570.06%

盘后：10.08-0.0157-0.16%16:04 EST

成交量：593.00

成交额：5,985.13

市值：6.62亿

市盈率：- -

高：10.10

开：10.08

低：10.08

收：10.09

52周最高：10.80

52周最低：9.94

股本：6,557.50万

流通股本：5,000.00万

量比：0.29

换手率：0.00%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：-5671.96

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

重要事件披露

Form 8-K - Current report

重要事件披露

Form 8-K - Current report

重要事件披露

Form 8-K - Current report

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DMIIU/filings"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"DMIIU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMIIU\",,,,,undefined,":{"symbol":"DMIIU","market":"US","secType":"STK","nameCN":"Drugs Made in America Acquisition Corp. II","latestPrice":10.0957,"timestamp":1771880400000,"preClose":10.09,"halted":0,"volume":593,"hourTrading":{"tag":"盘后","latestPrice":10.08,"preClose":10.0957,"latestTime":"16:04 EST","volume":2,"amount":20.16,"timestamp":1771880683367,"change":-0.0157,"changeRate":-0.001555,"amplitude":0},"delay":0,"changeRate":0.0005649157581765041,"floatShares":50000000,"shares":65575000,"eps":0,"marketStatus":"盘后交易","change":0.0057,"latestTime":"02-23 17:24:09 EST","open":10.08,"high":10.0957,"low":10.08,"amount":5985.133,"amplitude":0.001556,"askPrice":12.22,"askSize":100,"bidPrice":9.2,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771894800000},"marketStatusCode":4,"adr":0,"listingDate":1758772800000,"exchange":"NASDAQ","adjPreClose":10.09,"postHourTrading":{"tag":"盘后","latestPrice":10.08,"preClose":10.0957,"latestTime":"16:04 EST","volume":2,"amount":20.16,"timestamp":1771880683367,"change":-0.0157,"changeRate":-0.001555,"amplitude":0},"volumeRatio":0.289891},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMIIU\",,,,,undefined,":{"symbol":"DMIIU","floatShares":50000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.289891,"shares":65575000,"dividePrice":0,"high":10.0957,"amplitude":0.001556,"preClose":10.09,"low":10.08,"week52Low":9.935,"pbRate":"-5671.96","week52High":10.8,"institutionHeld":0,"latestPrice":10.0957,"eps":0,"divideRate":0,"volume":593,"delay":0,"ttmEps":0,"open":10.08,"prevYearClose":10.015,"prevWeekClose":10.09,"prevMonthClose":10.05,"prevQuarterClose":10.015,"fiveDayClose":10.08,"twentyDayClose":10.06,"sixtyDayClose":10},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMIIU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMIIU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMIIU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"DMIIU\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20427209","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112095-DMIIU","pdf_url":"","pub_time":1763499964000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMIIU","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/0001213900-25-112095-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea0265078-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0265078-10q_drugs2.htm","type":"10-Q","id":"NTFILE3gHfDgFy1TppTbwC","market":"us","size":458709},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex31-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex31-1_drugs2.htm","type":"EX-31.1","id":"NTFILE3ZkJxQZRd3EeLisV","market":"us","size":11978},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex31-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex31-2_drugs2.htm","type":"EX-31.2","id":"NTFILEHF6BGk8CrcBSXBPg","market":"us","size":11968},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex32-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex32-1_drugs2.htm","type":"EX-32.1","id":"NTFILE3iwbgjxjfvNF4tY7","market":"us","size":4610},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex32-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex32-2_drugs2.htm","type":"EX-32.2","id":"NTFILE5wiaZCMW2CDkWity","market":"us","size":4625}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-19 05:06","pubTimestamp":1763499964,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20426975","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025111706-DMIIU","pdf_url":"","pub_time":1763431473000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMIIU","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/0001213900-25-111706-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/ea0265998-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0265998-8k_drugs2.htm","type":"8-K","id":"NTFILE3BNBSxz4yQNim1RS","market":"us","size":47195}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-18 10:04","pubTimestamp":1763431473,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20235546","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025095513-DMIIU","pdf_url":"","pub_time":1759377600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMIIU","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/0001213900-25-095513-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED SEPTEMBER 26, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea025966201ex99-1_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea025966201ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILE4xx6SRsL6bNF6ztB","market":"us","size":114250},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea0259662-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0259662-8k_drugs2.htm","type":"8-K","id":"NTFILEHpw5vwSKLBE5mMCc","market":"us","size":18513}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-02 12:00","pubTimestamp":1759377600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20223602","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025093224-DMIIU","pdf_url":"","pub_time":1759118400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMIIU","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/0001213900-25-093224-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN THE COMPANY AND","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex1-1_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea025896901ex1-1_drugs2.htm","type":"EX-1.1","id":"NTFILEByXHkC741ydFfLAw","market":"us","size":263251},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea0258969-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0258969-8k_drugs2.htm","type":"8-K","id":"NTFILEC4zfL2p8wwEAuABZ","market":"us","size":45247},{"description":"AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex3-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex3-1_drugs2.htm","type":"EX-3.1","id":"NTFILEiRdpdi92TTwEEuSm","market":"us","size":286799},{"description":"RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN THE COMPANY AND CONTI","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex4-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex4-1_drugs2.htm","type":"EX-4.1","id":"NTFILEBznEbzBFRCWAsvDS","market":"us","size":68156},{"description":"LETTER AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG THE COMPANY, DRUGS MADE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-1_drugs2.htm","type":"EX-10.1","id":"NTFILE49pfazGrpXRq6uHX","market":"us","size":53854},{"description":"INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG TH","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-2_drugs2.htm","type":"EX-10.2","id":"NTFILE8d5X35P7D8ur9MZR","market":"us","size":98263},{"description":"REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG THE COMPAN","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-3_drugs2.htm","type":"EX-10.3","id":"NTFILEF49PsERKeDePmKXM","market":"us","size":105386},{"description":"PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-4_drugs2.htm","type":"EX-10.4","id":"NTFILE9ToHb4MBD1cdX2vi","market":"us","size":28320},{"description":"PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN T","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-5_drugs2.htm","type":"EX-10.5","id":"NTFILEC2tooddPpXDct9rE","market":"us","size":30246},{"description":"FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-6_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-6_drugs2.htm","type":"EX-10.6","id":"NTFILEDdFCZ259NpJxXBkY","market":"us","size":81365},{"description":"ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF SEPTEMBER 24, 2025, BY AND BETWEE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-7_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-7_drugs2.htm","type":"EX-10.7","id":"NTFILEBY2PatvzpmeyMjmE","market":"us","size":10653},{"description":"PRESS RELEASE DATED SEPTEMBER 25, 2025","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex99-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILEG5EixLWMqMHhajyp","market":"us","size":7950},{"description":"PRESS RELEASE DATED SEPTEMBER 26, 2025","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex99-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex99-2_drugs2.htm","type":"EX-99.2","id":"NTFILE6VUQ9BbU4BGqS9Dn","market":"us","size":8483},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILE6WtwtrUWJxakL88L","market":"us","size":12566}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-29 12:00","pubTimestamp":1759118400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；第5.03项：公司章程或章程的修订；财政年度的变化；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20256420","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025088044-DMIIU","pdf_url":"","pub_time":1757995200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMIIU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/0001213900-25-088044-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/ea0234544-09.htm","primary":true,"translateUrl":"","linkName":"ea0234544-09.htm","type":"S-1/A","id":"NTFILEDG9FLJe1VZch7sK9","market":"us","size":4594239},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/ea023454409ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023454409ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILE7hxyntNz6B4TBPDz","market":"us","size":49929}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-09-16 12:00","pubTimestamp":1757995200,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20256418","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025087444-DMIIU","pdf_url":"","pub_time":1757908800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMIIU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/0001213900-25-087444-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea0234544-08.htm","primary":true,"translateUrl":"","linkName":"ea0234544-08.htm","type":"S-1/A","id":"NTFILECxSbhTzQVVHT5uec","market":"us","size":4591246},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea023454408ex1-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454408ex1-1_drugs2.htm","type":"EX-1.1","id":"NTFILE2ZwQzNCQTiQY22VS","market":"us","size":252537},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea023454408ex5-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454408ex5-1_drugs2.htm","type":"EX-5.1","id":"NTFILEFgzLBqNiRUdpNMzN","market":"us","size":55574},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE8rquvrcv2BK1ArA1","market":"us","size":9247},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEFvKm68Y1qf1Hz6x8","market":"us","size":12840}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-09-15 12:00","pubTimestamp":1757908800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20256417","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025085167-DMIIU","pdf_url":"","pub_time":1757044800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMIIU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/0001213900-25-085167-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea0234544-06.htm","primary":true,"translateUrl":"","linkName":"ea0234544-06.htm","type":"S-1/A","id":"NTFILE3jLXk8NjyToAdNbd","market":"us","size":4565347},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE621bRSMd2uYub9Kw","market":"us","size":250437},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex5-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex5-1_drugs2.htm","type":"EX-5.1","id":"NTFILE5uNpcsmDRP5JG9Zw","market":"us","size":39364},{"description":"OPINION OF LOEB & LOEB LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex5-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex5-2_drugs2.htm","type":"EX-5.2","id":"NTFILECZkT7PtscjZknXWv","market":"us","size":11529},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex23-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex23-1_drugs2.htm","type":"EX-23.1","id":"NTFILE6D1tRKvVVoFU9RDP","market":"us","size":1909},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE9NyTjdGHHRHJ85aA","market":"us","size":11028},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE4ZSroPGjLib8nSmm","market":"us","size":12588},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEDBNiFm6BsYHexGA7","market":"us","size":12991}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-09-05 12:00","pubTimestamp":1757044800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20256425","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025065837-DMIIU","pdf_url":"","pub_time":1753070400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"DMIIU","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/0001213900-25-065837-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea0234544-04.htm","primary":true,"translateUrl":"","linkName":"ea0234544-04.htm","type":"S-1","id":"NTFILE9Wt59fi92xjofyAw","market":"us","size":4544925},{"description":"MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex3-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex3-1_drugs2.htm","type":"EX-3.1","id":"NTFILEA4y6eRbkoTwvuezK","market":"us","size":239206},{"description":"FORM OF AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex3-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex3-2_drugs2.htm","type":"EX-3.2","id":"NTFILEHkeCxFpE7Qmzh57p","market":"us","size":283955},{"description":"SPECIMEN UNIT CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-1_drugs2.htm","type":"EX-4.1","id":"NTFILEAWqfzKzNeN465XEF","market":"us","size":21282},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-2_drugs2.htm","type":"EX-4.2","id":"NTFILEFBtit5roDZ2fELCe","market":"us","size":20026},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-4_drugs2.htm","type":"EX-4.4","id":"NTFILE2LPc73qQZFDidqYq","market":"us","size":68499},{"description":"PROMISSORY NOTE, DATED AS OF SEPTEMBER 5, 2024, AS AMENDED, ISSUED TO DRUGS MADE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-1_drugs2.htm","type":"EX-10.1","id":"NTFILECcgS6q9cGpV3K3fa","market":"us","size":27200},{"description":"SECURITIES SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 10, 2024, BETWEEN THE REGISTR","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-2_drugs2.htm","type":"EX-10.2","id":"NTFILEJ8d3EVHRhPctW5Pa","market":"us","size":45653},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-3_drugs2.htm","type":"EX-10.3","id":"NTFILE9fFEqG4Q4yhYsqBZ","market":"us","size":44793},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-4_drugs2.htm","type":"EX-10.4","id":"NTFILE3KZ5squEAFTevC63","market":"us","size":96880},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT, DRUGS MADE IN AMERIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-5_drugs2.htm","type":"EX-10.5","id":"NTFILE3eXwkWUuhBau9rnu","market":"us","size":103172},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-6_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-6_drugs2.htm","type":"EX-10.6","id":"NTFILEEoAMvYjdiZfxjeq3","market":"us","size":27395},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND CANTOR FITZG","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-7_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-7_drugs2.htm","type":"EX-10.7","id":"NTFILE7XoLndqaXFrTsgd1","market":"us","size":28354},{"description":"FORM OF INDEMNITY AGREEMENT","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-8_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-8_drugs2.htm","type":"EX-10.8","id":"NTFILEEuXWjCrJ5tMXZAXJ","market":"us","size":81257},{"description":"FORM OF ADMINISTRATIVE SERVICES AGREEMENT BY AND BETWEEN THE REGISTRANT AND AN A","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-9_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-9_drugs2.htm","type":"EX-10.9","id":"NTFILEFK9EH6rvyP5sg3fw","market":"us","size":10757},{"description":"FORM OF CODE OF CONDUCT","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex14_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex14_drugs2.htm","type":"EX-14","id":"NTFILEJ51PhxvdyNPnKXGr","market":"us","size":49115},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex23-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex23-1_drugs2.htm","type":"EX-23.1","id":"NTFILE2dbNfrNiARKMFrg7","market":"us","size":2144},{"description":"CONSENT OF CATHERINE DO","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILE6GnKCcm5aLaLE6Ro","market":"us","size":2188},{"description":"CONSENT OF G. SRIDHAR PRASAD","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-2_drugs2.htm","type":"EX-99.2","id":"NTFILE2ATQuAYnTMBttnqX","market":"us","size":2104},{"description":"CONSENT OF MYRON W. SHULGAN","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-3_drugs2.htm","type":"EX-99.3","id":"NTFILE9HnQkR4U7PEckGq1","market":"us","size":2269},{"description":"FORM OF AUDIT COMMITTEE CHARTER","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-4_drugs2.htm","type":"EX-99.4","id":"NTFILE9q45a2rpGQd2domC","market":"us","size":38650},{"description":"FORM OF COMPENSATION COMMITTEE CHARTER","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-5_drugs2.htm","type":"EX-99.5","id":"NTFILEBp1jpuKnFu6a6KWb","market":"us","size":31779},{"description":"FILING FEE TABLE","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex-fee_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex-fee_drugs2.htm","type":"EX-FILING FEES","id":"NTFILEBB8AG7gYgswE6rxP","market":"us","size":20431},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILEH118fXoc7gSFoH6h","market":"us","size":9129},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ex3-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_002.jpg","type":"GRAPHIC","id":"NTFILEDesFHx9tirJjSozw","market":"us","size":7198}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-07-21 12:00","pubTimestamp":1753070400,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}